Vertex Pharmaceuticals | VRTX - EPS Earnings Per Share


Vertex Pharmaceuticals reported $4.47 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 4.88 4.80 Nov/09
FY2026Q2 Jun/2026 4.72 4.52 Aug/03
FY2026Q1 Mar/2026 4.47 4.43 4.06 May/04
FY2025Q4 Dec/2025 5.03 5.12 3.98 Feb/12
FY2025Q3 Sep/2025 4.80 4.62 4.38 Nov/03




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
Arrowhead Research USD -0.93 1.15 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 3.09 1.28 Jun/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
J&J USD 2.9 0.2 Jun/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026